These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 590919)

  • 21. [Studies on hemodynamics and functions of the pancreas. I. Effect of VIP on normal pancreas (author's transl)].
    Inoue K; Kawano T; Shima K; Kim T; Suzuki T; Tobe T; Yajima H
    Nihon Shokakibyo Gakkai Zasshi; 1980 Sep; 77(9):1413-23. PubMed ID: 7441916
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Tatemoto K; Efendić S
    Endocrinology; 1983 Apr; 112(4):1469-73. PubMed ID: 6339205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric inhibitory polypeptide and insulin secretion after infusion of acetylcholine, catecholamines, and gut hormones.
    Williams RH; Biesbroeck J
    Proc Soc Exp Biol Med; 1980 Jan; 163(1):39-47. PubMed ID: 7352145
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of gut hormone on insulin and glucagon secretion].
    Ohneda A; Eisentraut AM; Ketterer H; Unger RH
    Acta Diabetol Lat; 1968; 5(4):499-512. PubMed ID: 5720633
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of gut hormone on insulin and glucagon secretion].
    Ohneda A; Ketterer H; Eisentraut AM; Unger RH
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():191-203. PubMed ID: 4907220
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of glucagon, vasoactive intestinal peptide (VIP) and lysine-vasopressine on villous microcirculation and superior mesenteric artery blood flow of the rat.
    Holliger C; Radzyner M; Villiger A; Anliker M; Knoblauch M
    Bibl Anat; 1979; (18):129-31. PubMed ID: 496810
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of the intrapancreatic calcium and glucagon administration on the somatostain-induced inhibition of insulin and glucagon secretion in dogs (author's transl)].
    Usukura N; Yoshimitsu K; Sagara H; Kishitani M; Sakato S; Kawato M; Nakabayashi H; Takeda R
    Nihon Naibunpi Gakkai Zasshi; 1979 Mar; 55(3):201-9. PubMed ID: 437208
    [No Abstract]   [Full Text] [Related]  

  • 28. Gastrin releasing peptide stimulates the secretion of insulin, but not that of glucagon or somatostatin, from the isolated perfused dog pancreas.
    Hermansen K; Ahrén B
    Acta Physiol Scand; 1990 Feb; 138(2):175-9. PubMed ID: 1969219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrokinetic activity of secretion and secretin analogues, modified in the N-terminal sequence, and of vasoactive intestinal peptide in the dog pancreas.
    Lehnert P; Forell MM; Jaeger E; Moroder L; Wünsch E
    Digestion; 1981; 22(2):85-8. PubMed ID: 7274610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intrapancreatic injection of potassium and calcium on insulin and glucagon secretion in dogs.
    Kuzuya T; Kajinuma H; Ide T
    Diabetes; 1974 Jan; 23(1):55-60. PubMed ID: 4809620
    [No Abstract]   [Full Text] [Related]  

  • 31. A pure enteroglucagon, oxyntomodulin (glucagon 37), stimulates insulin release in perfused rat pancreas.
    Jarrousse C; Bataille D; Jeanrenaud B
    Endocrinology; 1984 Jul; 115(1):102-5. PubMed ID: 6376068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastrointestinal motility and gastrointestinal hormones].
    Takeuchi S; Aizawa I; Ito S
    Nihon Heikatsukin Gakkai Zasshi; 1977 Dec; 13(4):199-202. PubMed ID: 613112
    [No Abstract]   [Full Text] [Related]  

  • 33. Peptide YY: intrapancreatic localization and effects on insulin and glucagon secretion in the mouse.
    Böttcher G; Ahrén B; Lundquist I; Sundler F
    Pancreas; 1989; 4(3):282-8. PubMed ID: 2660131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal hormones and their functions.
    Johnson LR
    Annu Rev Physiol; 1977; 39():135-58. PubMed ID: 322595
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of secretin, glucagon and vasoactive intestinal peptide on the hormone-sensitive rat cardiac adenylate cyclase [proceedings].
    Chatelain P; Deschodt-Lanckman M; De Neef P; Christophe J; Robberecht P
    Arch Int Physiol Biochim; 1979 Oct; 87(4):783-4. PubMed ID: 93901
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of gut peptides on glucose-stimulated insulin release by monolayer cultures of neonatal rat islet cells.
    Fujimoto WY
    Horm Metab Res; 1981 Mar; 13(3):135-8. PubMed ID: 7016701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "In vitro" effects of secretin and vasoactive intestinal polypeptide on hydrolase secretion and cylic AMP levels in the pancreas of five animal species. A comparison with caerulein.
    Robberecht P; Deschodt-Lanckman M; Lammens M; De Neff P; Christophe J
    Gastroenterol Clin Biol; 1977; 1(6-7):519-25. PubMed ID: 196970
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intestinal factors in insulin secretion, with special reference to the role of glucagon].
    Brunetti P; Marri G
    Acta Diabetol Lat; 1968; 5(4):513-31. PubMed ID: 5720634
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Effect of gastrointestinal hormones on the phasic release on insulin from isolated islets of normal and obese hyperglycaemic mice.
    Best L; Atkins TW; Matty AJ
    J Endocrinol; 1975 Jun; 65(3):57P-58P. PubMed ID: 1097566
    [No Abstract]   [Full Text] [Related]  

  • 40. Action of natural glucagon on pancreatic acini: due to contamination by previously undescribed secretagogues.
    Pandol SJ; Sutliff VE; Jones SW; Charlton CG; O'Donohue TL; Gardner JD; Jensen RT
    Am J Physiol; 1983 Nov; 245(5 Pt 1):G703-10. PubMed ID: 6195929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.